Syndax Pharmaceuticals Inc Annual Net Income (Loss) Attributable to Parent in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Syndax Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2023.
  • Syndax Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$68.1M, a 52.6% decline year-over-year.
  • Syndax Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$264M, a 64.7% decline year-over-year.
  • Syndax Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$209M, a 40.2% decline from 2022.
  • Syndax Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$149M, a 699% decline from 2021.
  • Syndax Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was $24.9M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$209M -$60M -40.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 -$149M -$174M -699% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $24.9M +$98.1M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$73.2M -$17.1M -30.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$56M +$17.9M +24.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$74M -$13.2M -21.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 -$60.8M -$16.3M -36.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-05
2016 -$44.5M -$20.4M -84.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 -$24.1M -$4.29M -21.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 -$19.8M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.